INTRODUCTION
============

Infectious bursal disease virus (IBDV) causes a disease among young chickens and is of great economic importance to the poultry industry worldwide with regard to both mortality and immunosuppression ([@b19], [@b20], [@b24]). A member of the *Birnaviridae* family, IBDV contains a bisegmented dsRNA genome, designated A and B, within a non-enveloped icosahedral capsid of 60 nm in diameter. Segment A of the genome contains two partially overlapping open reading frames (ORFs). The first, small ORF encodes a 17 kD nonstructural host membrane-associated protein, VP5, and the second, large ORF encodes a 110 kD polyprotein that is auto-processed to produce the precursor of VP2 (pVP2), the multifunctional protein, VP3, and the viral protease, VP4. pVP2 is further processed to generate the outer capsid protein, VP2, which contains antigenic epitopes that are responsible for the induction of neutralizing antibodies. The segment B of the genome encodes a 90 kD VP1 protein with RNA-dependent RNA polymerase activity ([@b6], [@b16], [@b20], [@b24], [@b28]).

Two distinct serotypes of IBDV are recognized (1 and 2). Only serotype 1 is pathogenic for chickens and is classified according to the antigenicity and/or pathogenicity in classical virulent (cv) strains, very virulent (vv) strains, antigenic variant strains, and attenuated strains ([@b3], [@b25], [@b28]). The antigenic variation has been based on mutations in a hydrophilic hypervariable region of the VP2 gene ([@b4], [@b7], [@b20], [@b23]). More specifically, only a few amino acids (aa) in this region contribute effectively to the antigenicity ([@b28]). Although many reports have also considered the aa of this same region of VP2 as the determinants of virulence ([@b1], [@b19], [@b20], [@b24], [@b28]), further studies on the VP1 gene demonstrated the contribution of this gene to the virulence of IBDVs ([@b2], [@b17]). Both genes could be associated with the pathogenicity of IBDVs, yet the virulence markers remain unknown. Yamaguchi *et al.* ([@b29]) and Le Noüen *et al.* ([@b14]), studying the full genomic sequences from segments A and B, were able to define phylogenetically representative partial nucleotide sequences for use in molecular epidemiology studies. The purpose of this study was to analyze the partial sequences and phylogeny of Brazilian IBDV samples, as based on one of the regions of the VP1 gene, previously characterized as cv and vv strains by the partial sequence of VP2 ([@b8]).

MATERIALS AND METHODS
=====================

Field Strains
-------------

The bursae of Fabricius were collected from commercial layer and broiler chickens from São Paulo and Paraná States, Brazil, between 1997 and 2004. The tissues were previously prepared, and identified as IBDV ([@b8]) ([Table 1](#table1){ref-type="table"}).

###### 

Description of infectious bursal disease virus strains used in this study .

  Strain                                      Origin/Year       VP1 Gene      
  ------------------------------------------- ----------------- ------------- ----------
  Br/97/BA[A](#tf1-1){ref-type="table-fn"}    Brazil/1997       cv            HQ602714
  Br/00/BS[A](#tf1-1){ref-type="table-fn"}    Brazil/2000       vv            HQ602722
  Br/01/BGK[A](#tf1-1){ref-type="table-fn"}   Brazil/2001       vv            HQ602718
  Br/01/BGS[A](#tf1-1){ref-type="table-fn"}   Brazil/2001       vv            HQ602719
  Br/01/BGS[A](#tf1-1){ref-type="table-fn"}   Brazil/2001       vv            HQ602720
  ir/01/iNK[A](#tf1-1){ref-type="table-fn"}   Brazil/2001       vv            HQ602721
  Br/01/CA[A](#tf1-1){ref-type="table-fn"}    Brazil/2001       vv            
  Br/01/CB[A](#tf1-1){ref-type="table-fn"}    Brazil/2001       vv            HQ602723
  Br/01/CC[A](#tf1-1){ref-type="table-fn"}    Brazil/2001       vv            HQ602724
  Br/03/CK[A](#tf1-1){ref-type="table-fn"}    Brazil/2003       vv            HQ602725
  Br/03/DB[A](#tf1-1){ref-type="table-fn"}    Brazil/2003       vv            HQ602727
  Br/03/DQ[A](#tf1-1){ref-type="table-fn"}    Brazil/2003       vv            HQ602728
  Br/03/DR[A](#tf1-1){ref-type="table-fn"}    Brazil/2003       reassortant   HQ602717
  Br/03/DU[A](#tf1-1){ref-type="table-fn"}    Brazil/2003       vv            HQ602729
  Br/04/CR[A](#tf1-1){ref-type="table-fn"}    Brazil/2004       vv            HQ602726
  Br/04/DE[A](#tf1-1){ref-type="table-fn"}    Brazil/2004       cv            HQ602715
  Br/04/DN[A](#tf1-1){ref-type="table-fn"}    Brazil/2004       cv            HQ602716
  UK-661                                      UK/1994           vv            AJ878666
  OKYM                                        Japan/1997        vv            D49707
  99009                                       Brazil/99         vv            AJ878672
  94432                                       France/1994       vv            AJ878678
  variant A                                   USA/1985          variant       AJ878675
  Cu-lwt                                      German/1975       cv            AJ878644
  F52--70                                     UK/1970           cv            AJ878643
  23/82                                       Serotype 2/1985   aviralent     AJ878684
  02015.1                                     Venezuela/2002    reassortant   AJ878685
  02015.2                                     Venezuela/2002    reassortant   AJ878686
  ZJ2000                                      China/2000        reassortant   DQ166818
  SH95                                        China/2003        reassortant   AY134875
  02015.1                                     Venezuela/2002    reassortant   AJ878685
  CEVAC IBDL                                  vaccine           attenuated    AJ878660
  D78                                         vaccine           attenuated    AJ878654
  228E                                        vaccine           attenuated    AJ878657
  Bursine 2                                   vaccine           attenuated    AJ878655

Brazilian samples obtained in this study.

cv: classic virulent; vv: very virulent.

Reverse transcription and polymerase chain reaction (RT/PCR)
------------------------------------------------------------

The viral RNA from the bursal homogenates was extracted using the QIAamp Viral RNA Kit (Qiagen Inc., Valencia, CA) according to the manufacturer's instructions. The primer pair used for the partial amplification of a 594 bp fragment of the VP1 gene (nts 290 to 883) is described in Le Noüen *et al.* ([@b15]). The amplification conditions were adapted from Hernández *et al.* ([@b10]) for a one-tube procedure using the AccessQuick^TM^ RT-PCR System (Promega, Madison, WI) and a Perkin-Elmer Co. (Norwalk, CT) thermal cycler. An aliquot of 5 µl of viral dsRNA was mixed with 4.5 µl of ultra-pure water, denatured by boiling for 5 min at 98^o^C, and immediately immersed in ice for 5 min. The following mixture was then added to the tube: 12.5 µl of AccessQuick Master Mix (2x), 1 µl of each primer and 1 µl of AMV reverse transcriptase. The cDNA was synthesized at 42^o^C for 60 min, and the amplification included an initial denaturation step (5 min at 95^o^C) and 35 cycles of 95^o^C for 30 sec, 55^o^C for 1 min and 72^o^C for 1 min. A final extension was performed at 72^o^C for 5 min. The PCR products were subjected to electrophoresis through a 1.5% agarose gel supplemented with 1% ethidium bromide.

Nucleotide sequence and phylogenetic analysis
---------------------------------------------

The PCR products were purified using a PCR Purification Kit (Promega) and were sequenced using Big Dye Terminator Cycle Sequencing Ready Reaction (Applied Biosystems) and an ABI 377 automatic DNA sequencer. The sequences were aligned using Clustal X and subjected to a BLAST search, and the phylogenetic analysis was performed using the distance based neighbor-joining (NJ) method with the Kimura two-parameter option in PAUP 4.0 with 1,000 bootstrap replicates. Nucleotide accession numbers of the samples and the strains used for the comparison are shown in [Table 1](#table1){ref-type="table"}.

RESULTS
=======

A fragment of the VP1 gene, between the clusters a and b, that is representative of the region used for phylogenetic analysis was successfully amplified in the seventeen Brazilian IBDV samples from our previous study ([Table 1](#table1){ref-type="table"}). The nucleotide (nt) and amino acid (aa) sequences were compared among the samples and with those of the vaccine strains and other reported IBDV strains. The three previous cvVP2 IBDV samples were also classified as cv strains using the VP1 aa sequences. In thirteen of the samples identified as vvVP2, all of the four common and characteristic aa substitutions of the vv strains within the VP1 fragment were found ([Table 2](#table2){ref-type="table"}): the TDN tripeptide between aa 145--147 and 242E. The exception was the Br/03/DR sample that presented the conserved aa of the cv strains in these positions.

###### 

Tabl e 2.Amino acid (aa) exchanges within the VP1 fragment (68--248aa) in different infectious bursal disease virus strains.

                                          aa at positions           
  ------------------------- ------------- ----------------- --- --- ---
  Cu-lwt                    cv            N                 E   G   D
  F-52/70                   cv            N                 E   G   D
  Br/01/BJM^A^              cv            N                 E   G   D
  99009                     vv            T                 D   N   E
  UK661                     vv            T                 D   N   E
  OKYM                      vv            T                 D   N   E
  Br/03/DU^A^               vv            T                 D   N   E
  02015.1                   reassortant   T                 E   S   D
  02015.2                   reassortant   N                 E   G   T
  SH95                      reassortant   N                 E   G   D
  ZJ2000                    reassortant   T                 D   N   E
  Br/03/DR^A^               reassortant   N                 E   G   D
  variant A                 variant       N                 E   G   D
  D78, 228E and Bursine 2   vaccine       N                 E   G   D
  CEVAC                     vaccine       N                 E   D   D
  23/82                     serotype 2    N                 E   G   D

The identity percentages of the deduced aa sequence of the Br/03/DR sample with the others strains were determined. The sequence of this sample showed a higher identity with our Brazilian (Br) cv samples (93.6%-96.8%) than with the vv samples (91.0%-95.2%). However, the Br/03/DR sample had a 91.0% similarity to the sequences of the cv reference strains, 90.4%-91.0% to those of the vv strains and 91.5%-92.5% to the vaccine strains. Regarding the reassortant strains, our sample, Br/03/DR (vvVP2cvVP1), exhibited 92.0% similarity to the SH95 (vvVP2cvVP1) and 90.4% to the ZJ2000 (cvVP2vvVP1) strains. The phylogenetic tree of the predicted aa sequences of the VP1 gene fragment from our samples and the published IBDV strains is shown in [Figure 1](#fig1){ref-type="fig"}. Our vv samples branched together with the other vv strains and in a distinct cluster from the cv strains, which included our cv samples and the Br/03/DR sample. This profile of the Br/03/DR sample carrying vvVP2, but cvVP1, is indicative of a genetic reassortment.

![Phylogenetic tree of 13 Brazilian IBDV isolates (rhombus symbol), reference strains (cv and vv) and vaccines. The neighbor-joining analysis was based in predicted amino acid sequences of the fragment of the VP1 gene (aa 68--248) using the PAUP program. The bootstrap values were included in the branches since that \>50%.](bjm-43-1015-g001){#fig1}

DISCUSSION
==========

The fundamental molecular basis for the pathogenicity of IBDV is not entirely clear and remains questionable. To understand the circulating viruses in Brazil better, we continued our studies of the Brazilian samples from a period of seven years, which were previously classified as cv or vv strains by analysis of the VP2 gene ([@b8]), focusing on the VP1 gene in this study. Through sequencing, comparative alignments and phylogeny of the VP1 gene, all samples maintained the previous cv and vv assignments, except one (Br/03/DR).

Studies involving the multiple, full-length sequencing of the VP1 gene of diverse vv strains and from different countries have revealed the presence of 17 common aa residues, with eight that are unique to these strains ([@b5], [@b10], [@b13], [@b18], [@b29]). The Br/03/DR sample was the sole vvIBDV strain that did not present these common aa. Conversely, it presented the conserved aa of the cvIBDV strains, residue E146, which Ren *et al.* ([@b21]) correlated to the attenuated virulence of the Chinese isolate, YS07, together with two other residues (4I and S687). However, these authors also correlated other unique mutations in the VP2 sequence to the low mortality of this isolate. The role of cvVP1 in virulence of our sample cannot yet be fully established because of the absence of in vivo studies and full-length sequencing.

The phylogenetic tree constructed from the partial deduced aa sequences of VP1 showed that the Brazilian vvVP1 samples branched in a distinct cluster from the cvIBDV strains and even from the serotype 2 strain described in other studies ([@b5], [@b12], [@b29]). Phylogenetic studies with the VP1 gene of the vvIBDV strains suggested that the B segment is genetically distinct from that of all other IBDV strains, suggesting that the origin of the vvIBDVs is a a genetic reassortment of an unidentified source ([@b1], [@b12], [@b29]). Using the estimation of the time of emergence of the most recent common ancestor (TMRCA) and coalescence techniques in both genome segments to the IBDV, Hon *et al.* ([@b11]) verified that this segment B reassortment occurred in the mid-1980s, whereas the emergence of the vv A segment was 20 years prior. The authors concluded that the enhancement of virulence and the expansion of the vvIBDV strains in mid-1980s may be due to a synergistic effect of mutations on both of its genome segments. According to this conclusion, the Br/03/DR sample presenting a B segment derived from a cvIBDV strain, but with the segment A of a vvIBDV strain ([@b8]), could be a descendant of the IBDV ancestors before the reassortment of segment B of vvVP1.

It is known that the use of vaccines with intermediate virulence to control the disease by the vv strains can be responsible for a partial immunosuppression and mild bursal lesions. Although the viral multiplication does not revert the virulence, it could be the source of a genetic exchange producing a natural reassortant virus. Therefore, there is the risk of using live vaccines with the generation of such reassortments ([@b26], [@b27]). It could be another explanation for the origin of the Br/03/DR sample. Natural reassortments have mainly been described in China. The SH95 ([@b20]) and Gx ([@b9]) isolates and our Br/03/DR sample have vvVP2 and cvVP1. However, these two Chinese isolates maintained their virulence even without the vvVP1. Boot *et al.* ([@b1]) had initially verified that the VP1 gene would not have a major influence on the virulence of the vvIBDV strains. However, the ZJ2000 and TL2004 reassortants presented high virulence even without the presence of vvVP2 (cvVP2/vvVP1) ([@b26], [@b27]). In this case, the VP1 gene could be contributing to the enhanced virulence of these vvIBDVs, corroborating the further studies of Boot *et al.* ([@b2]).

High mutation rates occur in RNA viruses, but these variations are limited by functional constraints, and the rate of genomic reassortment events in nature is also low and depends on many factors. Gao *et al.* ([@b9]), in a quasispecies population study of the Gx isolate, found a much higher frequency of mutation in VP1 than in VP2, an unexpected result for a RNA polymerase. However, the most conserved region was correlated with another possible functional region. This isolate is also a reassortant, with VP2 derived from vvIBDV and VP1 from a cv strain and a retention of virulence. Studying more than 50 strains of IBDV of diverse years and localities, Le Noüen *et al.* ([@b15]) concluded that the co-evolution of both the A and B segments of IBDV is frequent, although they have also found a natural reassortant (strain 02015.1). Continuing studies of full-genome sequences and the pathogenicity in vivo are very important to understand the true role of VP1 in virulence and/or of the risk of the use of live vaccines and that will provide the exact relationship between the genetic composition and pathogenicity. Regardless, this is the first report of a natural genetic reassortment of IBDV strains in Brazil.
